Hatton Consulting’s Amgen AMGN Stock Holding History

Hatton Consulting’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,649	Closed	-$402K	–	43
2021 Q2	$402K	Buy	+1,649	New	+$406K	0.32%	33

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hatton Consulting's AMGN Position: Q3 2021 in Review

Hatton Consulting sold out of Amgen (AMGN) in Q3 2021, closing a stake of 1,649 shares — an estimated $402K sold.

Hatton Consulting first reported a position in AMGN in Q2 2021 and held it in 1 quarter. The position peaked at $402K in Q2 2021. 2,133 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

Hatton Consulting reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
Hatton Consulting sold 1,649 Amgen shares in Q3 2021, an estimated $402K.
Hatton Consulting first reported a position in Amgen in Q2 2021 and held it in 1 quarter.
Hatton Consulting's Amgen position peaked at $402K in Q2 2021.
2,133 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Hatton Consulting's 13F filing for Q3 2021, filed 14 Oct 2021.